Trending...
- Custom Disposables - Wholesale Packaging Solutions for restaurants, food chains, and food distributors
- Dominican Fashion Designer Raiza Bonaparte presents the Sovereign Despampanante Collection at the Library of Congress
- George Martinez Launches Community Re-distribution Initiative With Donation to the Gamma Alpha Alpha Chapter of Omega Psi Phi Fraternity, Inc
An analysis of psychiatric hospitals delivering ECT reveals a systemic failure to inform patients of risks the FDA recommended eight years ago. Failed oversight and court findings on brain damage are fueling renewed calls for a ban.
LOS ANGELES - Michimich -- By CCHR International
The Citizens Commission on Human Rights (CCHR) International reviewed more than 50 psychiatric hospitals across 23 states that administer electroconvulsive therapy (ECT). Their analysis found grossly inadequate risk information on their websites. None have updated materials to reflect the adverse effects the FDA required for mitigating risks in 2018. CCHR states that tens of thousands of Americans, including children, are not being warned about long-term memory loss and potential brain damage, warranting a government investigation and review of the need to ban ECT devices.
Thousands opposed the FDA's reclassification of ECT devices from high-risk Class III to lower-risk Class II for limited uses, with many calling for an outright ban. The FDA's 2018 final rule justified the change partly by requiring patient labeling to warn that "[t]he long-term safety and effectiveness of ECT treatment has not been demonstrated" and recommending formal neuropsychological assessments before and during treatment to monitor cognitive damage.[1] None of the facilities report this.
CCHR's review also shows the hospitals failed to warn of:
Federal agencies bear much of ECT's costs, even though psychiatrists admit it cannot cure and often requires ongoing "maintenance" treatments. A private insurance analysis found ECT patients hospitalized 4 to 29 days longer than those receiving standard treatment, with additional healthcare costs of $5,700 to $52,700.
Psychiatrists who practice ECT often earn roughly twice the salary of other psychiatrists. ECT is estimated to be a $5.05 – $7.6 billion-a-year industry.[2]
More on Michimich.com
ECT delivers up to 460 volts of electricity through the brain to induce a grand mal seizure, involving loss of consciousness and violent muscle contractions (masked by anesthetics and muscle relaxants). Higher voltages used today have increased risks. Devices were grandfathered in 1976 without premarket approval or clinical trials proving safety and efficacy.
The FDA's 2018 Final Rule specified there is no clinical data supporting safety and efficacy for schizophrenia, schizoaffective disorder, or mania (which remain Class III). Despite this, 71% (37) of the hospitals promote ECT for schizophrenia/schizoaffective disorders—including the Department of Veterans Affairs—and 35% (18) promote it for mania. The FDA lists mania and worsening psychiatric symptoms as adverse effects.
Some also promote it off-label for autism, Alzheimer's, Parkinson's, and dementia, despite ECT's known memory loss effects.
Many hospital claims are misleading and unsubstantiated, including:
The need for full informed consent regarding ECT has been upheld in courts, especially with a warning about potential brain damage.[3] Expert testimony before the Nebraska Supreme Court (2025) concluded that "ECT causes persistent or permanent memory loss and brain damage in a substantial proportion of recipients—somewhere between 12% and 55%," a finding which the court upheld.
Neuropathologists equate ECT's effects to traumatic brain injury, with victims suffering permanent cognitive impairment.[4]
The FDA erroneously believed that involuntary ECT is "uncommon" and always requires a judicial proceeding. In reality, state laws vary widely: six states have no ECT laws; many jurisdictions lack provisions for judicial oversight.[5] Only seven states require a court order for ECT on minors; 12 have no regulations for children.[6] Texas and California ban ECT on minors, due to CCHR's actions.
More on Michimich.com
Jan Eastgate, President of CCHR International, received ECT in 1975 after a misdiagnosis of hyperthyroidism as depression. "After antidepressants worsened my condition, I was told I needed ECT, that it was the same as jump-starting the heart, and there were no major side effects. It was a lie. The claims comparing it to dental work, childbirth, or defibrillating the heart are fraudulent, and the practice should be banned." She has dedicated her life since 1977 to warning others of the dangers and the need for thorough medical examinations to rule out undiagnosed physical conditions.
Psychiatrist Niall McLaren advises patients that any psychiatrist who tells them "'You need ECT' is really only saying, 'I don't know what else to do.'" He is adamant: "No psychiatrist needs to use ECT."[7]
CCHR, which was established in 1969 by the Church of Scientology and Dr. Thomas Szasz, professor of psychiatry, calls for individuals damaged by ECT to report the abuse to it and encourages families and doctors to watch its documentary, Electroshock: Therapy or Torture.
Sources:
[1] "Neurological Devices; Reclassification of Electroconvulsive Therapy Devices; Effective Date of Requirement for Premarket Approval for Electroconvulsive Therapy Devices for Certain Specified Intended Uses," Food and Drug Administration, 26 Dec. 2018
[2] Anne Marie McKersie, "Effects of Funding on Electroconvulsive Therapy in California," Master's Thesis, San Diego State University, Spring 2011
[3] John Read, Ph.D., "Landmark Electroconvulsive Therapy Case Settled Out of Court," Psychology Today, 16 June 2026
[4] "Electroconvulsive Shock 'Therapy' (ECT) Lawsuit," Wisner Baum, www.wisnerbaum.com/defective-medical-device-injuries/ect/
[5] Victoria Harris, MD, MPH, "Electroconvulsive Therapy: Administrative Codes, Legislation, and Professional Recommendation," Journal of the American Academy of Psychiatry & The Law, 4:406–11, 2006; Robin Livingston, et al., "Regulation of Electroconvulsive Therapy: A Systematic Review of US State Laws," National Library of Medicine, Mar. 2018
[6] Minju Hwang, et al., "Shock and Law: Unraveling State by State How and If ECT Can Be Offered for Psychiatric Conditions Occurring in Child and Adolescent Patients," Journal of the American Academy of Child & Adolescent Psychiatry, Oct. 2024
[7] Niall McLaren, "No Psychiatrist Needs to Use ECT," Mad In America, 27 June 2017
The Citizens Commission on Human Rights (CCHR) International reviewed more than 50 psychiatric hospitals across 23 states that administer electroconvulsive therapy (ECT). Their analysis found grossly inadequate risk information on their websites. None have updated materials to reflect the adverse effects the FDA required for mitigating risks in 2018. CCHR states that tens of thousands of Americans, including children, are not being warned about long-term memory loss and potential brain damage, warranting a government investigation and review of the need to ban ECT devices.
Thousands opposed the FDA's reclassification of ECT devices from high-risk Class III to lower-risk Class II for limited uses, with many calling for an outright ban. The FDA's 2018 final rule justified the change partly by requiring patient labeling to warn that "[t]he long-term safety and effectiveness of ECT treatment has not been demonstrated" and recommending formal neuropsychological assessments before and during treatment to monitor cognitive damage.[1] None of the facilities report this.
CCHR's review also shows the hospitals failed to warn of:
- Permanent memory loss (88%, 46 hospitals)
- Cardiovascular problems (69%, 36 hospitals)
- The right to refuse consent (88%, 46 hospitals)
Federal agencies bear much of ECT's costs, even though psychiatrists admit it cannot cure and often requires ongoing "maintenance" treatments. A private insurance analysis found ECT patients hospitalized 4 to 29 days longer than those receiving standard treatment, with additional healthcare costs of $5,700 to $52,700.
Psychiatrists who practice ECT often earn roughly twice the salary of other psychiatrists. ECT is estimated to be a $5.05 – $7.6 billion-a-year industry.[2]
More on Michimich.com
- Two Florida Family Law Firms Named Among the State's Best Divorce Practices for 2026
- Korey Hall Calls for Expansion of Behavioral Health Urgent Care Centers. Also Adds a Big Endorsment
- Tacoma Arts Live And Accelerating Creative Enterprise Present Ace Showace
- Shield Property Group Launches Full-Service Property Management Company Serving Southeast Michigan
- George Martinez Launches Community Re-distribution Initiative With Donation to the Gamma Alpha Alpha Chapter of Omega Psi Phi Fraternity, Inc
ECT delivers up to 460 volts of electricity through the brain to induce a grand mal seizure, involving loss of consciousness and violent muscle contractions (masked by anesthetics and muscle relaxants). Higher voltages used today have increased risks. Devices were grandfathered in 1976 without premarket approval or clinical trials proving safety and efficacy.
The FDA's 2018 Final Rule specified there is no clinical data supporting safety and efficacy for schizophrenia, schizoaffective disorder, or mania (which remain Class III). Despite this, 71% (37) of the hospitals promote ECT for schizophrenia/schizoaffective disorders—including the Department of Veterans Affairs—and 35% (18) promote it for mania. The FDA lists mania and worsening psychiatric symptoms as adverse effects.
Some also promote it off-label for autism, Alzheimer's, Parkinson's, and dementia, despite ECT's known memory loss effects.
Many hospital claims are misleading and unsubstantiated, including:
- "ECT is a minimally invasive treatment… like jump-starting a car battery" (A jump start typically uses 12 to 14 volts—ECT uses more than 30 times that.)
- ECT "turns the brain on and off just like a computer."
- ECT "can alter an individual's brain chemistry by releasing chemicals in the brain and encouraging the brain cells to make new connections."
- ECT is "no worse than going to the dentist."
The need for full informed consent regarding ECT has been upheld in courts, especially with a warning about potential brain damage.[3] Expert testimony before the Nebraska Supreme Court (2025) concluded that "ECT causes persistent or permanent memory loss and brain damage in a substantial proportion of recipients—somewhere between 12% and 55%," a finding which the court upheld.
Neuropathologists equate ECT's effects to traumatic brain injury, with victims suffering permanent cognitive impairment.[4]
The FDA erroneously believed that involuntary ECT is "uncommon" and always requires a judicial proceeding. In reality, state laws vary widely: six states have no ECT laws; many jurisdictions lack provisions for judicial oversight.[5] Only seven states require a court order for ECT on minors; 12 have no regulations for children.[6] Texas and California ban ECT on minors, due to CCHR's actions.
More on Michimich.com
- SITE Technologies Releases Industry Research Report Exposing the CapEx Intelligence Gap in Commercial Real Estate
- A Business Novel About Ambition, Ethics, and the Hidden Realities of International Business
- Kinetyc and Klear Unite to Remove Growth Barriers for the Next Generation of Manufacturers
- Century Fasteners Corp. Exhibiting at 2026 Farnborough International Airshow
- Compton to host first Juneteenth celebration with We Are Us Festival
Jan Eastgate, President of CCHR International, received ECT in 1975 after a misdiagnosis of hyperthyroidism as depression. "After antidepressants worsened my condition, I was told I needed ECT, that it was the same as jump-starting the heart, and there were no major side effects. It was a lie. The claims comparing it to dental work, childbirth, or defibrillating the heart are fraudulent, and the practice should be banned." She has dedicated her life since 1977 to warning others of the dangers and the need for thorough medical examinations to rule out undiagnosed physical conditions.
Psychiatrist Niall McLaren advises patients that any psychiatrist who tells them "'You need ECT' is really only saying, 'I don't know what else to do.'" He is adamant: "No psychiatrist needs to use ECT."[7]
CCHR, which was established in 1969 by the Church of Scientology and Dr. Thomas Szasz, professor of psychiatry, calls for individuals damaged by ECT to report the abuse to it and encourages families and doctors to watch its documentary, Electroshock: Therapy or Torture.
Sources:
[1] "Neurological Devices; Reclassification of Electroconvulsive Therapy Devices; Effective Date of Requirement for Premarket Approval for Electroconvulsive Therapy Devices for Certain Specified Intended Uses," Food and Drug Administration, 26 Dec. 2018
[2] Anne Marie McKersie, "Effects of Funding on Electroconvulsive Therapy in California," Master's Thesis, San Diego State University, Spring 2011
[3] John Read, Ph.D., "Landmark Electroconvulsive Therapy Case Settled Out of Court," Psychology Today, 16 June 2026
[4] "Electroconvulsive Shock 'Therapy' (ECT) Lawsuit," Wisner Baum, www.wisnerbaum.com/defective-medical-device-injuries/ect/
[5] Victoria Harris, MD, MPH, "Electroconvulsive Therapy: Administrative Codes, Legislation, and Professional Recommendation," Journal of the American Academy of Psychiatry & The Law, 4:406–11, 2006; Robin Livingston, et al., "Regulation of Electroconvulsive Therapy: A Systematic Review of US State Laws," National Library of Medicine, Mar. 2018
[6] Minju Hwang, et al., "Shock and Law: Unraveling State by State How and If ECT Can Be Offered for Psychiatric Conditions Occurring in Child and Adolescent Patients," Journal of the American Academy of Child & Adolescent Psychiatry, Oct. 2024
[7] Niall McLaren, "No Psychiatrist Needs to Use ECT," Mad In America, 27 June 2017
Source: Citizens Commission on Human Rights International
0 Comments
Latest on Michimich.com
- Optimal Facility Services Launches Nationwide Commercial Cleaning With Photo-Verified Quality
- Boston Industrial Solutions' Natron® 717N Series UV LED Ink Receives CPSIA Certification
- purelyIV Expands Mobile IV Therapy to Jackson, MI and Launches PlaqueX® IV Therapy
- Leimert Juneteenth Community Celebration Set for Friday, June 19, in Leimert Park Village
- UK Financial Ltd Publishes Maya Preferred Public Proof Package and CoinMarketCap Supply Verification Evidence
- Advancing High-Potential Nevada Critical Minerals Portfolio as Major Drill Program Nears Assay Results: Glenstar Minerals: Stock Symbol: GSTRF
- Parents Say the Exhausting Part Isn't the Activity Itself
- Allstream Energy Partners to Host 6th Executive Networking After 2026 Energy Projects Conference
- CAPHRA: Australia and Thailand show nicotine prohibition fuels illicit markets
- Custom Disposables - Wholesale Packaging Solutions for restaurants, food chains, and food distributors
- California Security Glass is an affordable bulletproof glass installation company in LA serving a variety of neighboring cities
- Allstream Energy Partners Announce Media Partnership with the 2026 EPC Show - The Energy Projects Conference
- STO Foundation Launching June 29, 2026 to Advance the Global Tokenization Industry
- Restaurant Hotline Plus Launches Interactive HTML Workbooks for Restaurant Operators
- West Virginia Leaders Announce Support for Election Integrity Network's Model Election Laws Handbook
- CCHR Condemns Behavioral Treatment After FDA's Missed Deadline to Ban Shock Device
- Roofman USA Educates Ann Arbor Homeowners on What Insurance Covers After Storm Damage
- Brilliant Minds to Gather in Fort Worth for National Mensa Event
- Bidvii Launches Local Drops: A vertical video -Style Local Sale Feed Powered by AI
- UK Financial Ltd Completes One Of The Most Extensive CoinMarketCap Supply Verification Packages For Maya Preferred PRA (MPRA)
